Jordan
Mubasher TV
 Contact Us Advertising   العربية
Jordan
ASE Closed
02 April 06:36 PM

Hikma Pharmaceuticals PLC (HIK)

Last update: 20 November 2007 01:44 PM market time.
19.20
-1.25
-6.11%
Open 19.90
Previous Close 20.45
High 19.90
Low 19.20
Stock Statistics
Volume 200
Turnover 3,910.00
All data are 15 minutes late during market session

General Information

Company Name Hikma Pharmaceuticals PLC (HIK)
Company Purpose Hikma Pharmaceuticals PLC (knwon as:Hikma) is a public company, listed on Nasdaq Dubai since April 2006. Hikma operates within the Pharmaceuticals, Biotechnology & Life Sciences sector focusing on Pharmaceuticals. Hikma is based in London, UK and was established in Sptember 2005.
Company Establish Date 08 September 2005
Financial Year Start
Auditor
  • PricewaterhouseCoopers LLP - United Kingdom

Ownership

  • Darhold Ltd (25.56%)
  • Mazen Darwazah (0.5931%)
  • Ali Al Husry (0.4954%)
  • Said Darwazah (0.3632%)
  • Riad Mishlawi (0.0568%)
  • Nina Henderson (0.003%)
  • Douglas Hurt (0.0019%)
  • Patrick Butler (0.0017%)
  • John Castellani (0.0015%)
  • Cynthia Schwalm (0.0005%)
  • Deneen Vojta (0.0004%)

Management

Said Samih Taleb Darwazah Chairman
Riad Mishlawi CEO
Mazen Samih Taleb Darwazah Board Members
Laura Balan Board Members
Victoria Hull Board Members
Douglas Hurt Board Members
Cynthia Schwalm Board Members
Nina Henderson Board Members
Ali Al Husry Board Members
Deneen Vojta Board Members

Subsidiaries

  • Hikma Pharmaceuticals USA Inc. (100.00%)
  • Specialised for Pharmaceutical Industries LLC (100.00%)
  • Sofia Travel and Tourism Co (100.00%)
  • International Pharmaceutical Research Centre LLC (100.00%)
  • Arab Medical Containers LLC (100.00%)
  • Hikma Services India Private Limited (100.00%)
  • Hikma France Co (100.00%)
  • Hikma Pharmaceuticals Industries S.A.E (100.00%)
  • Hikma Co (100.00%)
  • Hikma Canada Limited (100.00%)
  • Al Jazeera Pharmaceutical Industries Ltd (100.00%)
  • Hikma Pharma Industry (100.00%)
  • Hikma Injectables USA, Inc. (100.00%)
  • West Ward Columbus Inc Co (100.00%)
  • Hikma Labs Inc Co (100.00%)
  • Hikma Speciality USA.inc (100.00%)
  • Hikma Pharmaceuticals International Limited (100.00%)
  • West Ward Holdings Limited (100.00%)
  • A P M Tunisie S.A.R.L. (100.00%)
  • Hikma Spain Co (100.00%)
  • Hikma Pharmaceuticals (100.00%)
  • SPA Al Dar Al Arabia pour la Fabrication de Médicament (100.00%)
  • Hikma Mena Holdings Ltd (100.00%)
  • Hikma Benelux BV (100.00%)
  • Eurohealth USA Inc (100.00%)
  • Hikma Pharma Ltd (100.00%)
  • Hikma Ltd (100.00%)
  • Eurohealth International SARL (100.00%)
  • Thymoorgan Pharmazie GmbH (100.00%)
  • Hikma International Pharmaceuticals Co Ltd (100.00%)
  • Hikma Pharma - Germany GmbH (100.00%)
  • Hikma Farmaceutica SA - Portugal (100.00%)
  • Lifotec Farmaceutica S.G.P.S S.A (100.00%)
  • Societe Medicef Ltd (100.00%)
  • Hikma Ventures (100.00%)
  • Hikma Finance USA LLC (100.00%)
  • Hikma International Trading Limited (100.00%)
  • Hikma Emereging Markets Asia Pacific FZ- LLC (100.00%)
  • Hikma Pharma Egypt Co (100.00%)
  • Hikma Pharmaceutical For Forign Companieys Head Quarter Co (100.00%)
  • Hikma Pharmaceuticals Co LLC - Jordan (100.00%)
  • Hikma for Importation Co. LLC (99.00%)
  • Al Jazeera Pharmaceutical Industry S.A.R.L (99.00%)
  • Hikma Specialised Pharmaceuticals (S.A.E) (98.00%)
  • Algerie Industrie Mediterraneene Du Medicament S.A.R.L. (Algeria) (97.00%)
  • Amiantit Fiberglass Industries India Pvt Ltd (51.00%)
  • Hikma Care for Medicines and Medical Supplies Co (51.00%)
  • Hubei Haosun Pharmaceutical Co (49.00%)

Contacts

Address 1 New Burlington Place, London W1S 2HR
Phone +44 20 73992760
Fax +44 20 73992761
Website www.hikma.com
Email [email protected]
Contact Person Guy Featherstone